Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line

Journal of Clinical Pathology - Molecular Pathology

Volumn 55, Issue 4, 2002, Pages 262-272

  Le Rouzic, E ^a   Thoraval, P ^b   Afanassieff, M ^b   Cherel, Y ^c   Dambrine, G ^b   Perbal, Bernard ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CEMAGREF   (France)

^c LUNAM UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BIRD DISEASE; CARCINOGENICITY; CHICKEN; CONTROLLED STUDY; GENE DISRUPTION; GENE EXPRESSION; GENE MAPPING; GENE SEQUENCE; LYMPHOBLASTOID CELL; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; ONCOGENE C MYB; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; RNA ANALYSIS; RNA PURIFICATION; ROUS SARCOMA ONCOVIRUS; SINGLE STRAND CONFORMATION POLYMORPHISM; VIRUS GENOME; VIRUS LATENCY; VIRUS PATHOGENESIS;

ANIMALS; CELL TRANSFORMATION, VIRAL; CHICKENS; GENES, MYB; GENOME, VIRAL; HERPESVIRUS 2, GALLID; LYMPHOMA, T-CELL; MAREK DISEASE; NUCLEAR PROTEINS; ONCOGENES; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED; VIRAL PROTEINS; VIRULENCE;

EID: 0036347937     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.55.4.262     Document Type: Article

References (68)

1. The Leeuwenhoek Lecture. Marek's disease herpesvirus: Oncogenesis and prevention
2. Structure of Marek's disease virus DNA: Detailed restriction enzyme map
3. The genome of a very virulent Marek's disease virus
4. The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus
5. T-cell transformation by Marek's disease virus
6. The attenuation with loss of oncogenicity of the herpes-type virus of Marek's disease virus (strain HPRS-16) on passage in cell culture
7. The structure of Marek disease virus DNA: The presence of unique expansion in nonpathogenic viral DNA
8. Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage
9. Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage
10. Alterations in DNA sequence and RNA transcription of the Bam HI-H fragment accompany attenuation of oncogenic Marek's disease herpesvirus
11. Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamHI-H
12. The inhibitory effects of oligonucleotides, complementary to Marek's disease virus mRNA transcribed from the BamHI-H region, on the proliferation of transformed lymphoblastoid cells, MDCC-MSB1
13. Prolonged proliferation of primary chicken embryo fibroblasts transfected with cDNAs from the BamHI-H gene family of Marek's disease virus
14. A 7 kDa protein encoded by the BamHI-H gene family of Marek's disease virus is produced in lytically and latently infected cells
15. Identification of an immediate-early gene in the Marek's disease virus long internal repeat region which encodes a unique 14-kilodalton polypeptide
16. Marek's disease virus type 1-specific phosphorylated proteins pp38 and pp24 with common amino acid termini are encoded from the opposite junction regions between the long unique and inverted repeat sequences of viral genome
17. Expression of the Marek's disease virus homolog of herpes simplex virus glycoprotein B in Escherichia coli and its identification as B antigen
18. Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells
19. Complete nucleotide sequence of the Marek's disease virus ICP4 gene
20. Evidence that Marek's disease virus exists in a latent state in a sustainable fibroblast cell line
21. Identification of latency-associated transcripts that map antisense to the ICP4 homolog gene of Marek's disease virus
22. Marek's disease virus latency-associated transcripts belong to a family of spliced RNAs that are antisense to the ICP4 homolog gene
23. Identification of novel transcripts complementary to the Marek's disease virus homologue of the ICP4 gene of herpes simplex virus
24. Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors
25. Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ
26. Marek's disease virus EcoRI-Q gene (meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek's disease lymphomas
27. Transforming potential of the herpesvirus oncoprotein MEQ: Morphological transformation, serum-independent growth, and inhibition of apoptosis
28. Functional interactions between herpesvirus oncoprotein MEQ and cell cycle regulator CDK2
29. Transactivation activity of Meq, a Marek's disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells
30. Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein
31. Enhanced expression of the Marek's disease virus-specific phosphoproteins after stable transfection of MSB-1 cells with the Marek's disease virus homologue of ICP4
32. Retroviral insertional activation of the c-myb proto-oncogene in a Marek's disease T-lymphoma cell line
33. Chicken thymocyte-specific antigens identified by monoclonal antibodies: Characterization and distribution in normal tissues and in tumoral tissues from Marek's disease chicken
34. Development of anti-tumoral cell-mediated cytotoxicity during the course of Marek's disease in chickens
35. Two cell lines from lymphomas of Marek's disease
36. T lymphoblastoid cell lines from Marek's disease lymphomas
37. Induction of lymphoblastoid leukosis transplantable tumors and the establishment of lymphoblastoid cell lines
38. Continuous lines of AMV-transformed non-producer cells: Growth and oncogenic potential in the chick embryo
39. Transformation of brown leghorn chicken embryo fibroblasts by avian myeloblastosis virus proviral DNA
40. Alloimmune hemolytic plaque-forming cells: Kinetics of IgM and IgG alloantibody releasing cells during a primary and secondary immune response of chickens
41. Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer
42. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter
43. Expression of the mRNA coding for glyceraldehyde-3-phosphate dehydrogenase
44. Construction and properties of a turkey herpesvirus recombinant expressing the Marek's disease virus homologue of glycoprotein B of herpes simplex virus
45. The transcripts from the sequences flanking the short component of Marek's disease virus during latent infection form a unique family of 3′-caterminal RNAs
46. Molecular analysis of the glycoprotein C-negative phenotype of attenuated Marek's disease virus
47. Isolation and characterization of Marek's disease virus (MDV) cDNAs from a MDV-transformed lymphoblastoid cell line: Identification of an open reading frame antisense to the MDV Eco-Q protein (Meq)
48. Characterization of the protein product encoded by a splicing variant af the Marek's disease virus Eco-Q gene (Meq)
49. Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI·L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV
50. Characterization of five isolates af Marek's disease
51. Two gene families of Marek's disease virus (MDV) with a potential role in tumor induction in chicken
52. Marek's disease: An update on oncogenic mechanisms and control
53. Meq: An MDV-specific bZIP transactivator with transforming properties
54. The structure of Marek's disease virus DNA: Amplification of repeat sequence in IRs and TRs
55. Structure of the Marek's disease virus BamHI-H gene family: Genes of putative importance for tumor induction
56. Cis-acting elements in the lytic origin of DNA replication of Marek's disease virus type 1
57. Inhibition of Marek's disease virus DNA transfection by a sequence containing an alphaherpesvirus origin of replication and flanking transcriptional regulatory elements
58. Genome analysis of Marek's disease virus strain CVI-988: Effect of cell culture passage on the inverted repeat regions
59. Purification and characterization of infectious Marek's disease virus genomes using pulsed field electrophoresis
60. Latent Marek's disease virus can be activated from its chromosomally integrated state in herpesvirus-transformed lymphoma cells
61. Status of Marek's disease virus in established lymphoma cell lines: Herpesvirus integration is common
62. Integration of multiple chicken retroviruses into multiple chicken herpesviruses: Herpesviral gD as a common target of integration
63. Retrovirus insertion into herpesvirus in vitro and in vivo
64. Retroviral insertional mutagenesis of a herpesvirus: A Marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication
65. Insertion of tandem direct repeats consisting of avian leukosis virus LTR sequences into the inverted repeat region of Marek's disease virus type 1 DNA
66. Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo
67. Transformation of chicken myelomonocytic cells by a retrovirus expressing the v-myb oncogene from the long terminal repeats of avian myeloblastosis virus but not Rous sarcoma virus